CNBC October 29, 2024
Key Points
– Pfizer reported third-quarter revenue and adjusted profit that blew past expectations.
– The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales.
– It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.
Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company’s Covid vaccine and antiviral pill Paxlovid helped boost sales.
The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to $2.95, up from its previous guidance of 2.45 to $2.65 per share.
Pfizer now expects revenue in a range of $61 billion to $64...
Today's Sponsors
Today's Sponsor